These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6433466)

  • 41. DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease.
    Warrier AI; Lusher JM
    J Pediatr; 1983 Feb; 102(2):228-33. PubMed ID: 6401806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved detection of haemophilia A carriers by factor VIII related antigen (radioimmunoassay) and bleeding symptoms.
    Wahlberg T; Blombäck M
    Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):339-46. PubMed ID: 6791292
    [No Abstract]   [Full Text] [Related]  

  • 43. Factor VIII competitive enzyme assay: observations in von Willebrand's variants and hemophiliacs.
    Yorde LD; Yorde DE; Sasse EA; Hussey CV
    Clin Physiol Biochem; 1984; 2(6):298-303. PubMed ID: 6440727
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Development of a competitive enzyme immunoassay for factor VIII-related antigen].
    Riemer J; Kopperschläger G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(1):72-83. PubMed ID: 6202602
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An in vivo study of a new factor VIII high purity preparation.
    Thorell L; Blombäck M; Blombäck B
    Thromb Res; 1983 Jul; 31(2):375-85. PubMed ID: 6415854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inheritable molecular variants of moderate and mild hemophilia A.
    Ljung R; Holmberg L; Nilsson IM
    Acta Med Scand; 1981; 209(1-2):11-6. PubMed ID: 6782836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Associations between type of product and inhibitors in previously untreated patients (PUPs) with severe hemophilia: switches and particular products can disturb analysis.
    Calvez T; Laurian Y; Goudemand J
    Blood; 2007 Aug; 110(3):1073-4; author reply 1074-5. PubMed ID: 17644742
    [No Abstract]   [Full Text] [Related]  

  • 48. Studies on the relationship between factor VIII related antigen (VIIIRAg) and factor VIII clotting antigen (VIIICAg) by immunoelectrophoresis and autoradiography using 125I anti VIIICAg.
    Davies BL; Furlong RA; Peake IR
    Thromb Res; 1981 Apr 1-15; 22(1-2):87-96. PubMed ID: 6794178
    [No Abstract]   [Full Text] [Related]  

  • 49. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
    Miller CH; Kelley L; Green D
    Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A HindIII RFLP and a gene lesion in the coagulation factor VIII gene.
    Bernardi F; Legnani C; Volinia S; Patracchini P; Rodorigo G; DeRosa V; Marchetti G
    Hum Genet; 1988 Apr; 78(4):359-62. PubMed ID: 2896159
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Artificial factor VIII deficient plasma: preparation using monoclonal antibodies and its use in one stage coagulation assays.
    Hornsey VS; Waterston YG; Prowse CV
    J Clin Pathol; 1988 May; 41(5):562-7. PubMed ID: 3133400
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunoradiometric assay of VIII:CAg, a potential tool to detect human anti-VIII:C antibodies.
    Hellings JA; van Leeuwen FR; Over J; van Mourik JA
    Thromb Res; 1982 May; 26(4):297-302. PubMed ID: 6810499
    [No Abstract]   [Full Text] [Related]  

  • 53. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J; Peake I; Bloom A
    Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Progress and problems in hemophilia and von Willebrand's disease.
    Abildgaard CF
    Adv Pediatr; 1984; 31():137-77. PubMed ID: 6440429
    [No Abstract]   [Full Text] [Related]  

  • 55. Elevation of total progressive antithrombin in von Willebrand's disease.
    Barrow ES; Graham JB
    Thromb Res; 1978 Jul; 13(1):61-7. PubMed ID: 308713
    [No Abstract]   [Full Text] [Related]  

  • 56. Factor VIII/von Willebrand factor. Structure and function.
    Zimmerman TS
    Ann N Y Acad Sci; 1987; 509():53-9. PubMed ID: 2447817
    [No Abstract]   [Full Text] [Related]  

  • 57. [Inhibitors and "bypass" therapy in hemophilia].
    Fukutake K; Fukutake K
    Nihon Rinsho; 1981; 39(12):3688-99. PubMed ID: 6803034
    [No Abstract]   [Full Text] [Related]  

  • 58. Immunologic studies of antihemophilic factor (AHF, VIII:C). VI. Characterization of antigenic determinants using human antibodies.
    Gawryl MS; Hoyer LW
    Clin Immunol Immunopathol; 1982 May; 23(2):517-26. PubMed ID: 6179670
    [No Abstract]   [Full Text] [Related]  

  • 59. Factor VIII-related antigen pre-peak on crossed immunoelectrophoresis: a non-random phenomenon.
    Miller CH; Hilgartner MW; LeStrange RC; McLaughlin GW
    Thromb Res; 1982 Jan 1-15; 25(1-2):101-7. PubMed ID: 6801807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Possible cross-linking of factor VIII related antigen to fibrin by factor XIII in delayed coagulation process.
    Hada M; Kato M; Ikematsu S; Fujimaki M; Fukutake K
    Thromb Res; 1982 Jan 1-15; 25(1-2):163-8. PubMed ID: 6801810
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.